Berger Dietmar 4
4 · Atara Biotherapeutics, Inc. · Filed May 8, 2019
Insider Transaction Report
Form 4
Berger Dietmar
Global Head of R&D
Transactions
- Tax Payment
Common Stock
2019-05-07$33.46/sh−4,322$144,614→ 85,678 total
Footnotes (1)
- [F1]Shares withheld to cover tax obligation from settlement of vested restricted stock units.